Literature DB >> 26147809

Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.

Jun Wang1,2, Shuying Liu3, Yifei Cao4, Lei Yang4, Yue Chen5, Veenu Minhas6, Charles Wood6, Tiejun Zhang1,2.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) may be transmitted via sexual contacts, but limited information is available on KSHV infection status among sexually transmitted infection (STI) patients in China. The main objective of the present study was to determine the KSHV seroprevalence and its risk factors among male STI patients. A cross-sectional survey was conducted in three prefectures of Anhui province, China, between June and September 2013. A total of 1,600 male patients who visited an STI clinic were invited, and 1,372 participated in the study. Data were abstracted from the medical records for all the patients. Blood samples were collected and tested for antibodies to KSHV, HIV, HCV, and syphilis. Factors associated with KSHV seropositivity were examined using multivariable logistic regression analysis. The overall prevalence of KSHV, HIV, HCV, and syphilis was 13.3%, 0.7%, 0.6%, and 12.5%, respectively. After adjusting for potential confounders, KSHV infection was significantly associated with ever having anal sex with men (19 out of 30 males, OR: 8.64, 95%CI: 1.92-38.79) and HIV infection (six out of nine HIV-positive individuals, OR: 8.39, 95%CI: 1.80-39.04). There were no significant associations of KSHV infection with drug use, heterosexual sex behaviors, syphilis, and HCV. Our finding has shown that a relatively moderate prevalence of KSHV was found among male STI patients. While an increased risk for KSHV infection was observed among participants with homosexual contacts. Routine KSHV testing is recommended for male individuals attending STI clinics.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  China; Kaposi's sarcoma-associated herpesvirus; prevalence

Mesh:

Substances:

Year:  2015        PMID: 26147809     DOI: 10.1002/jmv.24321

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Molecular Epidemiology of Kaposi's Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014.

Authors:  Khashayar Hesamizadeh; Hossein Keyvani; Farah Bokharaei-Salim; Seyed Hamidreza Monavari; Maryam Esghaei; Fatemeh Jahanbakhsh Sefidi
Journal:  Iran Red Crescent Med J       Date:  2016-06-19       Impact factor: 0.611

2.  Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus and herpes simplex virus type 2 infections among adults: evidence from the NHANES III data.

Authors:  Xin Zhang; Yiyun Xu; Yi Li; Huangbo Yuan; Zhenqiu Liu; Tiejun Zhang
Journal:  Virol J       Date:  2022-01-06       Impact factor: 4.099

3.  Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China.

Authors:  Tiejun Zhang; Zhenqiu Liu; Jun Wang; Veenu Minhas; Charles Wood; Gary M Clifford; Na He; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2017-05-30       Impact factor: 2.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.